Ledger.Open graph →

SEC Form D · Amendment · filed August 1, 2023

VITARA BIOMEDICAL, INC

Offering

$75.0M

Sold

$25.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PHILADELPHIA, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

John Kelly · Philadelphia, PAExec Ted Fjallman · Philadelphia, PADirector Ian Ratcliffe · Philadelphia, PADirector Bernard Lyons · Philadelphia, PADirector Thomas Todorow · Philadelphia, PADirector Diem Nguyen · Philadelphia, PADirector Rosaleen Oskanian · Philadelphia, PAExec James Mcglone · Philadelphia, PAExec · Director Manish Kothari · Philadelphia, PADirector Fei Wu · HONG KONG, Hong KongDirector Rishi Malhotra · New York, NYDirector Wayne Grube, Jr · Baltimore, MDDirector Bernard A. Fox, Iii · Portland, ORDirector John Krambeer · El Segundo, CAExec Derren Burrell · KNOXVILLE, TNDirector Chris Abraham · Chicago, ILExec Xiaorui Bao · HONG KONG, Hong KongExec · Director Michael Phipps · Charlotte, NCDirector Steven W. Gfroerer · Waukee, IAExec Kari J. Cooling · Waukee, IAExec Conrad J. Suszynski · FORT WORTH, TXDirector John C. Goff · FORT WORTH, TXDirector Andrew P. Lombardi · FORT WORTH, TXDirector Carol Reynolds · Grand Cayman, Cayman IslandsDirector Gary Gladstein · Grand Cayman, Cayman IslandsExec · Director Dennis Hunter · Grand Cayman, Cayman IslandsDirector Reto Ringger · Zurich, V8Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗